endoscopic ultrasonography guided cystogastrostomy: Nasojejunal tube will be placed post EUS-CG or oral diet would be started after randomization
Study summary
The goal of this randomized control trial is to assess whether nasojejunal feed is better than oral nutrition in patients who are undergoing endoscopic cystogastrostomy of walled off necrosis following acute pancreatitis. It will also try to answer, the incidence of infections and feed tolerance.
The main question it tries to answer is
1. whether nasojejunl feed is better than oral feed in patients undergoing endoscopic cystogastrostomy in walled off necrosis following acute pancreatitis
2. How much infections they develop, whether they are able to tolerate the feed, weight gain and reintervention rates in each group
Eligibility
Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
1. Patients of acute pancreatitis (AP) with 18-75 years of age
2. Patients with symptomatic WON requiring EUS guided transluminal drainage
3. Provision of written informed consent
Exclusion Criteria:
1. Patients with collection not amenable for EUS guided drainage (distance of WON \>1 cm from the gastrointestinal lumen)
2. Known malignancy or immunocompromised state
3. Previous upper gastrointestinal(GI) surgery interfering with absorption
4. Active GI bleeding
5. GI obstruction, ileus or persistent vomiting
6. Patients moribund to undergo endoscopic procedure (Glasgow coma scale \<8 or patients on ventilatory support)
7. Patients with irreversible coagulopathy like platelets \<50,000/mm3 and/or INR\>1.5
8. Pregnant or lactating female
Primary outcome measure(s)
Nutritional failure — 14 days To compare the rate of nutritional failure at Day 14 between Nasojejunal and oral feeding post endoscopic transmural drainage of WON
Trial sites (1)
Facility
City
Region
Status
Post Graduate Institute of Medical Education and Research (PGIMER)
Chandigarh
India
Recruiting
More Post Graduate Institute of Medical Education and Research, Chandigarh trials in India
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.